Sayansan, Raphy P.
HRN: 23-65-25 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/07/2023
CEFTRIAXONE 1G (VIAL)
09/07/2023
09/14/2023
IV
1 Gram
Q12H
Immunocompromised State
Waiting Final Action
Indication: Empiric Type of Infection: Multiple Infections (tick All Sites)Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes